[HTML][HTML] Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV …
V Ivashkin, V Fomin, S Moiseev, M Brovko… - … and antimicrobial proteins - Springer
The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911 …
V Ivashkin, V Fomin, S Moiseev… - Probiotics & …, 2023 - search.ebscohost.com
The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
[引用][C] Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV …
V Ivashkin, V Fomin, S Moiseev, M Brovko… - Probiotics and …, 2021 - elibrary.ru
Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911 …
V Ivashkin, V Fomin, S Moiseev… - Probiotics and …, 2023 - search.proquest.com
The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911 …
V Ivashkin, V Fomin, S Moiseev, M Brovko… - 2023 - pubmed.ncbi.nlm.nih.gov
The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911 …
V Ivashkin, V Fomin, S Moiseev, M Brovko… - Probiotics and …, 2021 - europepmc.org
The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
[HTML][HTML] Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV …
V Ivashkin, V Fomin, S Moiseev, M Brovko… - Probiotics and …, 2023 - ncbi.nlm.nih.gov
The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
Efficacy of a probiotic consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911 …
V Ivashkin, V Fomin, S Moiseev, M Brovko… - 2021 - cabidigitallibrary.org
The treatment of coronavirus disease (COVID-19) and COVID-19-associated diarrhea
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …
remains challenging. This study aimed to evaluate the efficacy of a multi-strain probiotic in …